Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors

Published:2024-03 Issue:3 Volume:175 Page:605-612
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Beyer Gabriella V.^ORCID,Hueser Sophia^ORCID,Li Rachel,Manika Deeraj,Lee Minhyuk,Chan Carlos H.F.^ORCID,Howe James R.^ORCID,Ear Po Hien^ORCID

Publisher

Elsevier BV

Subject

Surgery

Reference31 articles.

1. Neuroendocrine tumors of the pancreatobiliary and gastrointestinal tracts;Bonds;Surg Clin North Am,2020

2. Epidemiologic trends of and factors associated with overall survival for patients with gastroenteropancreatic neuroendocrine tumors in the United States;Xu;JAMA Netw Open,2021

3. Gastroenteropancreatic neuroendocrine tumors;Cives;CA Cancer J Clin,2018

4. Emerging treatment options for gastroenteropancreatic neuroendocrine tumors;Cives;J Clin Med,2020

5. Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors;Maire;Neuroendocrinology,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP